Company information:
Dyax Ltd (No: 08965623)
Address: 1 KINGDOM STREET, LONDON, W2 6BD, ENGLAND
Status: Active - Proposal to Strike off
Incorporated: 28-Mar-2014
Accounts Next Due: 30-Sep-2020
Next Confirmation Statement Due: 04-Nov-2020
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: MARK GIBBONS ( DOB: Jan-1984 From: Jun-2018 )
Current Director: JONATHAN CLARK NEAL ( DOB: Aug-1971 From: Apr-2019 )
Current Secretary: SHIRE CORPORATE SERVICES LIMITED ( From: Mar-2018 )
Resigned Director: ANDREW D. ASHE ( From: Mar-2014 To: Apr-2016 )
Resigned Director: DAMIEN RODOLPHE EDMOND BAILLY ( DOB: Jul-1966 From: Jan-2018 To: May-2019 )
Resigned Director: FEARGHAS MACGILP KERR CARRUTHERS ( DOB: Apr-1970 From: Dec-2017 To: Jun-2018 )
Resigned Director: HELEN ROSEMARY JANAWAY ( DOB: May-1975 From: Apr-2016 To: Jun-2017 )
Resigned Director: GEORGE MIGAUSKY ( From: Mar-2014 To: Apr-2016 )
Resigned Director: LESLEY SHARON ROCHE ( DOB: Apr-1967 From: Apr-2016 To: Oct-2016 )
Resigned Director: KETAN JAYSUKHLAL SEDANI ( DOB: Nov-1971 From: Nov-2017 To: Dec-2017 )
Resigned Director: SEBASTIAN STACHOWIAK ( From: Apr-2016 To: Nov-2017 )
Resigned Director: JONATHAN IVAN WILLIAM WEBB ( DOB: Jul-1975 From: Nov-2016 To: Jun-2018 )
Persons of Significant Control:
Shire Plc, 22 Grenville Street, St Helier, JE4 8PX, Jersey: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2016-04-06, Ceased: 2019-01-08)
Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-Chome, Chuo-Ku, Osaka, Japan: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2019-01-08)